Celldex Therapeutics Inc.

NASDAQ:CLDX  
47.40
+0.90 (+1.94%)
Earnings Announcements

Celldex Provides Corporate Update And Reports Fourth Quarter And Year End 2020 Results

Published: 03/29/2021 20:15 GMT
Celldex Therapeutics Inc. (CLDX) - Celldex Provides Corporate Update and Reports Fourth Quarter and Year End 2020 Results.
Q4 Revenue $3.8 Million Versus $3.6 Million.
Q4 Loss per Share $0.55.
Q4 Earnings per Share Estimate $-0.37 -- Refinitiv Ibes Data (analyst estimates).
Believes Cash, Cash Equivalents, Marketable Securities Sufficient to Fund Planned Operations Through 2023.
Revenue is expected to be $1.22 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $1.12 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.